Wellington Management Group LLP 13D/13G Filings for Dicerna Pharmaceuticals, Inc. (DRNA)

Wellington Management Group LLP 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-04
11:40 am
Purchase
2020-12-3113GDicerna Pharmaceuticals, Inc.
DRNA
Wellington Management Group LLP4,317,623
5.750%
3,648,932increase
(+545.68%)
Filing